We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$369M
AUM Growth
+$18.1M
Cap. Flow
-$6.35M
Cap. Flow %
-1.72%
Top 10 Hldgs %
45.57%
Holding
168
New
3
Increased
14
Reduced
34
Closed
2

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$378K
2
LLY icon
Eli Lilly
LLY
+$252K
3
MDT icon
Medtronic
MDT
+$175K
4
GILD icon
Gilead Sciences
GILD
+$170K
5
INTC icon
Intel
INTC
+$159K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$952K
2
V icon
Visa
V
+$431K
3
ROP icon
Roper Technologies
ROP
+$337K
4
ALB icon
Albemarle
ALB
+$296K
5
IQV icon
IQVIA
IQV
+$285K

Sector Composition

Rank Sector Weight
1 Technology 31.9%
2 Healthcare 14.1%
3 Financials 12.95%
4 Communication Services 11.09%
5 Consumer Staples 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
51
Coca-Cola
KO
$373B
$576K 0.16%
9,283
+2,453
+36% +$149K
T icon
52
AT&T
T
$166B
$539K 0.15%
27,997
+2,500
+10% +$47.8K
F.PRB icon
53
Ford Motor Co 6.20% Notes due June 1 2059
F.PRB
$612M
$532K 0.14%
21,700
– –
ROST icon
54
Ross Stores
ROST
$79.6B
$531K 0.14%
5,000
– –
FVRR icon
55
Fiverr
FVRR
$311M
$500K 0.14%
14,315
– –
BRK.B icon
56
Berkshire Hathaway Class B
BRK.B
$1.09T
$498K 0.13%
1,612
– –
AMGN icon
57
Amgen
AMGN
$225B
$463K 0.13%
1,916
– –
VRTX icon
58
Vertex Pharmaceuticals
VRTX
$133B
$463K 0.13%
1,468
-140
-9% -$42K
XOM icon
59
ExxonMobil
XOM
$657B
$457K 0.12%
4,169
– –
ET.PRD
60
DELISTED
Energy Transfer LP 7.625% Series D Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Unit
ET.PRD
$423K 0.11%
18,300
+1,800
+11% +$43K
COF.PRI icon
61
Capital One Financial Series I Preferred Stock
COF.PRI
$1.07B
$414K 0.11%
20,800
– –
INTC icon
62
Intel
INTC
$509B
$398K 0.11%
12,185
+5,600
+85% +$159K
MMM icon
63
3M
MMM
$94.8B
$352K 0.1%
4,005
+1,196
+43% +$113K
REGN icon
64
Regeneron Pharmaceuticals
REGN
$82.2B
$316K 0.09%
385
– –
LLY icon
65
Eli Lilly
LLY
$1.09T
$257K 0.07%
+747
New +$252K
HON icon
66
Honeywell
HON
$74.6B
$250K 0.07%
1,390
– –
AWR icon
67
American States Water
AWR
$3.49B
$247K 0.07%
2,780
– –
OKE icon
68
Oneok
OKE
$58.3B
$244K 0.07%
3,843
– –
NEE icon
69
NextEra Energy
NEE
$179B
$236K 0.06%
3,060
– –
MITT.PRB
70
TPG Mortgage Investment Trust 8.00% Series B Preferred Stock
MITT.PRB
$93.9M
$194K 0.05%
12,000
– –
AMZN icon
71
Amazon
AMZN
$2.88T
$188K 0.05%
1,820
– –
ISRG icon
72
Intuitive Surgical
ISRG
$142B
$187K 0.05%
732
– –
ZTS icon
73
Zoetis
ZTS
$30.4B
$179K 0.05%
1,075
– –
OGN icon
74
Organon & Co
OGN
$3.59B
$174K 0.05%
7,383
– –
MDT icon
75
Medtronic
MDT
$116B
$173K 0.05%
+2,150
New +$175K
1 2
3
4 5

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $361M AUM 21.17% 1-Year Est. Return

Kelly Lawrence W & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Kelly Lawrence W & Associates held 168 positions worth $369M, up 5.2% from $351M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 3%. Kelly Lawrence W & Associates opened 3 new positions and exited 2, leaving the 168-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Kelly Lawrence W & Associates's largest Q1 2023 buy was Eli Lilly: 747 shares worth $257K.
  • Kelly Lawrence W & Associates added most to American Tower in Q1 2023, an estimated $378K increase.
  • Kelly Lawrence W & Associates's biggest Q1 2023 reduction was Apple, cutting an estimated $952K.
  • Kelly Lawrence W & Associates fully exited Walmart Inc in Q1 2023, selling an estimated $105K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 46% of its $369M portfolio in Q1 2023.
  • Kelly Lawrence W & Associates opened 3 new positions and closed 2 in Q1 2023.
  • Kelly Lawrence W & Associates's portfolio value rose 5.2% quarter-over-quarter to $369M.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2023, filed 15 May 2023.